Page last updated: 2024-10-24

candesartan cilexetil and Zika Virus Infection

candesartan cilexetil has been researched along with Zika Virus Infection in 2 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Zika Virus Infection: A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Loe, MWC1
Lee, RCH1
Chu, JJH1

Other Studies

2 other studies available for candesartan cilexetil and Zika Virus Infection

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
    Antiviral research, 2019, Volume: 172

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antiviral Agents; Benzimidazoles; Biphenyl Compoun

2019